{"id":407,"date":"2021-10-27T18:35:34","date_gmt":"2021-10-27T18:35:34","guid":{"rendered":"https:\/\/endouroloji.org.tr\/?p=407"},"modified":"2022-01-05T13:44:28","modified_gmt":"2022-01-05T13:44:28","slug":"vol-13-issue-1","status":"publish","type":"post","link":"https:\/\/endourolojibulteni.com\/en\/vol-13-issue-1\/","title":{"rendered":"Vol 13 Issue 1"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">Editorial Board Message<\/h3>\n\n\n\n<p>Prof. Dr. Sel\u00e7uk G\u00dcVEN<\/p>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Editor.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Editorial Borad<\/h3>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Broadcasting_Board.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Arbitrators List<\/h3>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Arbtitration_Board.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Contents<\/h3>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Contents.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><strong><em>Original Article<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Evaluation of success and complications using the Guy\u2019s stone score and modified Clavien rating system in percutaneous nephrolithotomy<\/h3>\n\n\n\n<p>Do\u011fukan S\u00f6kmen, Yusuf \u0130lker \u00c7\u00f6mez, Volkan Tu\u011fcu<\/p>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>Abstracts<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<p><strong>Objective: <\/strong>Urinary system stone disease has been one of the leading diseases that negatively affect human life and quality of life throughout history. Our aim is to present the percutaneous nephrolithotomy experience of three centers in our country in all aspects (patient selection, success, additional treatment requirement, complications, mortality) and to shed light on future studies. <\/p>\n\n\n\n<p><strong>Material And Methods: <\/strong>Classical PNL and miniPNL with full records; The data of 944 patients from 3 centers were evaluated retrospectively. Kidney stones were classified using the Guy Stone Scoring system (Guy\u2019s Stone Score, GSS) based on stone burden and localization. Clavien classification, modified by them in 2004, was used for per-operative and post-operative complications in patients. In statistical analysis; success, the need for additional treatment, the effect of complications on complications and percentage rates were compared using the chi-square test, and p &lt;0.05 was considered statistically significant. Independent factors affecting success, complications, and additional treatment were determined using logistic regression analysis. <\/p>\n\n\n\n<p><strong>Results:<\/strong> In 662 of our 944 patients (70.13%), success was achieved in direct urinary system radiography and \/ or non-contrast abdominal CT taken on the first postoperative day without any rest stones. After additional treatment applied to 23.30% of the patients, this rate increased to 83.65% in the postoperative 6th month. The success rate for stones in the GSS 1 group was 90.06% and was quite high. This ratio was statistically significant compared to the GSS 3 and GSS 4 groups (p &lt;0.001). The success rate increases significantly in groups with low GSS scores. A total of 478 complications were observed in 435 (46.08%) of 944 patients operated on. When we arrange these data according to the modified Clavien grading system, 159 (16.84%) in grade 1, 152 (16.10%) in grade 2, 113 (11.97%) in grade 3a, 15 in grade 3b ( 1.58%), 9 (0.95%) in grade 4a, 1 (0.10%) in grade 4b, and 1 (0.10%) in grade 5 were observed. When the distribution of complications by stone groups was examined, it was observed that all grade 4a, 4b, and grade 5 complications were seen in GSS 4 group stones. <\/p>\n\n\n\n<p><strong>Conclusion:<\/strong> The complex classification of kidney stones can be eliminated using the \u201cGuy Stone Score\u201d. It is categorized in a simple way and the probabilities of success and complications are predicted. Complications can be standardized using the \u201cModified Clavien Grading\u201d. In addition, the classifications shed light on clinical research and studies. <\/p>\n\n\n\n<p><strong>Keywords:<\/strong> Kidney stones, GSS, Clavien, percutaneous nephrolithotomy, complications, stone-free<\/p>\n\n<\/div><\/details><\/div>\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Perkutan_nefrol%C4%B1%CC%87totom%C4%B1%CC%87de_guy_tas_skoru.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><strong><em>Original Article<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Urosepsis after endoscopic urinary system stone treatment: factors increasing risk<\/h3>\n\n\n\n<p>Dilek Bulut, Merve Sefa Sayar, Ender Cem Bulut, Alper Bitkin, Fatih B\u0131\u00e7akl\u0131o\u011flu, Serhat \u00c7etin, Murat Yavuz Koparal, Kas\u0131m Erta\u015f<\/p>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>Abstracts<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<p><strong>Objective: <\/strong>Urinary system stones are an increasingly common disease that creates serious financial burden on the health system. Urinary infections are substantial after endoscopic treatment of urolithiasis with ureterorenoscopy (rigid or flexible). In this study, we examined the incidence of urosepsis in patients applied endoscopic stone treatment with ureterorenoscopy and the factors that increase it. Thus, we aimed to contribute to the discussion on measures to be taken to prevent urosepsis in patients. <\/p>\n\n\n\n<p><strong>Material And Methods: <\/strong>Patients who underwent endoscopic stone treatment with ureterorenoscopy for kidney or ureteral stones were included in the study. The two groups, which were divided into those with and without urosepsis, were compared with each other in terms of age, gender, comorbidity, and residual stones. <\/p>\n\n\n\n<p><strong>Results: <\/strong>The total number of patients included in the study was 561. The median age of the patients included in the study was 39 (18-77). Sepsis findings were observed in 12 (4.2%), 31 (14.2%) and 9 (16.7%) patients, respectively, in patients grouped according to the age range of 18-40, 41-60 and 61-80 years. There was a significant difference between these groups in terms of the incidence of urosepsis (p &lt;0.001). While 39 (25.3%) patients had urosepsis in the patient group with comorbidity, 13 (3.2%) patients had urosepsis in the patient group without comorbidity. A statistically significant difference was found between the two groups in terms of the rates of urosepsis (p &lt;0.001). <\/p>\n\n\n\n<p><strong>Conclusion:<\/strong> Recognizing the factors that facilitate postoperative urosepsis is important for effective prophylaxis and effective antibiotherapy in treatment. Findings to be obtained with high patient numbers may decrease the cost and morbidity rates created by urosepsis. <\/p>\n\n\n\n<p><strong>Keywords:<\/strong> urosepsis, endourology, antibiotherapy, urolithiasis<\/p>\n\n<\/div><\/details><\/div>\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Endoskopik_Uriner_Sistem_Tas_Tedavisi_Sonrasi.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><strong><em>Original Article<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mini percutaneus nephrolithotomy: the contrubition of the new system to our practice<\/h3>\n\n\n\n<p>Yusuf \u0130lker \u00c7\u00f6mez, Do\u011fukan S\u00f6kmen<\/p>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>Abstracts<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<p><strong>Objective:<\/strong> In this study, the evaluation of the patients who were operated with Minimal Invasive Percutaneus Nephrolithotomy (MIP) approach is aimed.<\/p>\n\n\n\n<p><strong>Material And Methods: <\/strong>The data of consecutive 50 mPNL patients between January 2016- January 2017<br>were obtained and retrospectively evaluated. All patients were evaluated in terms of anesthesiology risks,<br>patient positions, access locations, stone sizes, stone clearence rates, postoperative drainage requirement<br>and complications.<\/p>\n\n\n\n<p><strong>Results: <\/strong>All patients have undergone mPNL procedures. Mean stone size was 20 (12-33) mm and mean<br>stone number was 1 (1-3). Mean stone clearence rate was 98% (97-100). Complication rate was 6% while<br>transfusion necessity was 2%.<\/p>\n\n\n\n<p><strong>Conclusion: <\/strong>mPNL with MIP system, with its low complication rate, easy access to all calyceal systems and<br>advantages of different patient posisitons, may be a good alternative to cPNL, even to ureterorenoscopy<br>and ESWL.<\/p>\n\n\n\n<p><strong>Keywords: <\/strong>Mini-PNL, PNL, Percutaneous nephrolithotomy, MIP, Minimally invasive<\/p>\n\n<\/div><\/details><\/div>\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Mini_Perkutan_Nefrolitotomi_Yeni_sistemlerin_pratigimize_katkilari.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><strong><em>Original Article<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Our experience of retrograde intrarenal surgery in the treatment of upper urinary tract stones<\/h3>\n\n\n\n<p>Yasin Yitgin, Ayhan Karak\u00f6se, Ekrem Akdeniz<\/p>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>Abstracts<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<p><strong>Objective: <\/strong>The purpose of this study was to evaluate results for patients with renal or proximal ureter stone<br>disease and undergoing retrograde intrarenal surgery (RIRS).<\/p>\n\n\n\n<p><strong>Material And Methods: <\/strong>Demographic, clinical, operative and postoperative datas from 99 patients who<br>underwent RIRS for upper urinary tract stones between March 2019 and May 2020 were analyzed retrospectively. Non-contrast computed tomography (CT) was routinely performed on all patients. Stone location and size were assessed using CT. Achieving stone-free status or residual stone size \u2264 2 mm were<br>regarded as operational success.<\/p>\n\n\n\n<p><strong>Results:<\/strong> RIRS was performed on 99 patients, 60 (60.6%) men and 39 (39.4%) women, with a mean age of<br>44.9 \u00b1 13.1 years. RIRS was applied to the right unit in 48 patients and to the left in 50. The procedure was<br>performed on both sides in the same session in one case. The stone was in the kidney in 78 patients and<br>in the proximal ureter in 21. The mean stone burden was 18.5 \u00b1 6.9 mm, and the mean operative time was<br>70.6 \u00b1 23.8 minutes. All patients were discharged on the first postoperative day. No complications occurred<br>during surgery or the postoperative period. The stone free rate was 90.9%.<\/p>\n\n\n\n<p><strong>Conclusion: <\/strong>We believe that the RIRS procedure is a minimally invasive technique that can be used instead<br>of percutaneous nephrolithotomy as experience increases and technology advances.<\/p>\n\n\n\n<p><strong>Keywords: <\/strong>Flexible ureterorenoscopy, retrograde intrarenal surgery, upper urinary tract stone<\/p>\n\n<\/div><\/details><\/div>\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Ust_uriner_sistem_taslari_tedavisinde_retrograd_intrarenal_cerrahi_deneyimlerimiz.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><strong><em>Case Report<\/em><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Bladder cancer and genetic backround in young patients<\/h3>\n\n\n\n<p>Ali Erhan Eren, Selim Ta\u015f<\/p>\n\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>Abstracts<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<p>Although bladder cancer can be seen at any age, it is rarely seen in young patients. Patients often present<br>with the complaint of painless clotted hematuria. Although there is no exact age range for young patients<br>in the literature, published papers have defined classifications as under 20 years old, between 20 and 40<br>years old and over 40 years old. The PI3K pathway and the associated PIK3CA gene are located on chromosome 9.<br>In this case report, we aimed to present a young patient with PIK3CA gene mutation that has unclear effects on bladder cancer. A 22-year-old male patient applied to center. Ultrasonography showed a 6&#215;4 cm<br>papillary mass near the base of the left lateral wall of the bladder. Subsequently, transurethral resection<br>was performed. Histopathological examination established the diagnosis of superficial low-grade papillary<br>urothelial carcinoma (pTa Low-Grade) based on the WHO\/ISUP 2004 classification.<br>It was concluded that the PIK3CA gene mutation in this case may be related to bladder cancer.<\/p>\n\n\n\n<p><strong>Keywords:<\/strong> bladder cancer, genetic background, young pat\u0131ents<\/p>\n\n<\/div><\/details><\/div>\n\n<div class=\"lightweight-accordion\"><details><summary class=\"lightweight-accordion-title\"><span>PDF<\/span><\/summary><div class=\"lightweight-accordion-body\">\n\n<figure class=\"wp-block-image is-resized\"><a href=\"https:\/\/endourolojibulteni.com\/bultenler\/EndourologyBulletin-13-1-Genc_Hastada_Mesane_Tumoru_ve_Genetik_Altyapi.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"https:\/\/endourolojibulteni.com\/images\/pdf-ikon.png\" alt=\"\" width=\"68\" height=\"56\"\/><\/a><\/figure>\n\n<\/div><\/details><\/div>","protected":false},"excerpt":{"rendered":"<p>Editorial Board Message Prof. Dr. Sel\u00e7uk G\u00dcVEN Editorial Borad Arbitrators List Contents Original Article Evaluation of success and<\/p>\n","protected":false},"author":1,"featured_media":1230,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,2,8],"tags":[],"class_list":["post-407","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-archive","category-endourology-bulletin","category-home-page"],"_links":{"self":[{"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/posts\/407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/comments?post=407"}],"version-history":[{"count":16,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/posts\/407\/revisions"}],"predecessor-version":[{"id":1586,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/posts\/407\/revisions\/1586"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/media\/1230"}],"wp:attachment":[{"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/media?parent=407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/categories?post=407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/endourolojibulteni.com\/en\/wp-json\/wp\/v2\/tags?post=407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}